Article Versions Notes

Karkhanis AV, Harwood MD, Stader F, Bois FY, Neuhoff S. Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework. Pharmaceutics. 2024; 16(10):1284. https://doi.org/10.3390/pharmaceutics16101284

Karkhanis, Aneesh V., Matthew D. Harwood, Felix Stader, Frederic Y. Bois, and Sibylle Neuhoff. 2024. "Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework" Pharmaceutics 16, no. 10: 1284. https://doi.org/10.3390/pharmaceutics16101284

Karkhanis, A. V., Harwood, M. D., Stader, F., Bois, F. Y., & Neuhoff, S. (2024). Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework. Pharmaceutics, 16(10), 1284. https://doi.org/10.3390/pharmaceutics16101284